Industry Overview of Post-marketing Pharmacovigilance and Medical Information Market
IMARC Group, a leading market research company, has recently releases report titled “Post-marketing Pharmacovigilance and Medical Information Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global post-marketing pharmacovigilance and medical information market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
What is Post-marketing Pharmacovigilance and Medical Information?
Post-marketing pharmacovigilance and medical information represents the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It generally includes surveillance, collection, and prevention of adverse effects of new medicines, therapies, equipment, etc. Post-marketing pharmacovigilance and medical information helps to protect patients from unnecessary harm by refuting false indications and clarifying risks concerning benefits. It aids researchers in determining required actions throughout the drug formulation cycle. Consequently, post-marketing pharmacovigilance and medical information is extensively utilized in the healthcare industry to assess the accuracy of the delivered information between medical professionals and patients. It also finds wide-ranging applications across research organizations for regulating drug safety guidelines.
How big is the Post-marketing Pharmacovigilance and Medical Information Market?
Report Attributes
Details
Market Size in 2022
US$ 5.1 Billion
Market Forecast in 2028
US$ 9.4 Billion
Growth rate (2023 to 2028)
CAGR of 10.9%
Base Year of the Analysis
2022
Forecast Period
2023-2028
What Are the Growth Prospects and Trends in The Post-marketing Pharmacovigilance and Medical Information Industry?
The rising prevalence of hypertension, diabetes, dementia, cardiovascular diseases, and osteoporosis is primarily driving the post-marketing pharmacovigilance and medical information market. Additionally, the growing prevalence of adverse drug reactions (ADRs) is further bolstering the market growth. Apart from this, the launch of various favorable policies by government bodies to improve healthcare infrastructures and pharmacovigilance services and maintain medical databases is acting as another significant growth-inducing factor. Moreover, the development of cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility is positively influencing the global market. Besides this, key market players are also focusing on outsourcing pharmacovigilance operations (PVO), which is also catalyzing the market growth. Furthermore, the increasing number of clinics, hospitals, laboratories, and medical research centers and the expanding geriatric population are anticipated to fuel the post-marketing pharmacovigilance and medical information market over the forecasted period.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Breakup by Product:
Books
Online Media
Journals
Breakup by End User:
Hospitals
Research Organization
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Accenture Plc.
ArisGlobal
Cognizant Technology Solutions Corporation
Ergomed Plc
Hoffmann-La Roche Ltd.
Icon Plc
Parexel International Corporation
Pharmaceutical Product Development
and Wipro Ltd.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/